What's New
Nirmatrelvir with ritonavir (Paxlovid®) for patients with COVID-19April 6, 2022
Nirmatrelvir with ritonavir (Paxlovid®) is now available for patients with COVID-19 who are at high risk of severe disease. This bulletin discusses drug interactions that can occur with ritonavir, some of which may be potentially life-threatening. Further information on use of Paxlovid® can be found at: Ministry of Health – Therapeutics for the treatment of […]
Bulletin: Complementary and Alternative Products – QualityNovember 17, 2021
The use of complementary and alternative products (CAPs) such as herbals, dietary supplements, probiotics and homeopathic products is very common. However, most products sold in Aotearoa NZ are unregulated. This bulletin describes the problems reported regarding the quality of CAPs. CAP Quality
WORLD ANTIMICROBIAL AWARENESS WEEK 18 – 24 November 2021: Spread Awareness, Stop ResistanceNovember 17, 2021
Antimicrobial resistance is a growing problem in Aotearoa New Zealand and globally it is a crisis. This year the focus of the Awareness Week is on improving the understanding for both health professionals and patients of penicillin allergy and the harms associated with incorrect allergy labelling. CDHB Antimicrobial Stewardship Committee has produced the following bulletins […]
Prazosin supply issuesOctober 15, 2021
PHARMAC has an agreement with Arrotex NZ to supply prazosin tablets from 1st November 2021. This may leave a short gap in supply since local wholesalers estimate supply of 2 and 5 mg tablets will be depleted by late October (1 mg tablets are already out of stock). Pharmacies may need to ration amount supplied […]
